ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1195 • ACR Convergence 2024

    The Relations of Analgesic Antidepressants Use to Knee or Hip Replacement Among Osteoarthritis Patients Compared to Selective Serotonin Reuptake Inhibitors in a Large Prospective Cohort

    Zhiqiang Wang1, Maggie Westerland2, Christine Peloquin3, mike LaValley4, Margaret Clancy3, Changhai Ding5 and Tuhina Neogi3, 1Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, Guangdong, China (People's Republic), 2Boston University School of Medicine, Boston, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 4Boston University School of Public Health, Arlington, MA, 5Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, China (People's Republic)

    Background/Purpose: Some antidepressants and anticonvulsants are effective in treating pain through mechanisms thought to be independent from their effects on depression, such as tricyclic antidepressants…
  • Abstract Number: 1485 • ACR Convergence 2024

    Genetic Contributions to Systemic Lupus Erythematosus: Concordance Rates in California Twins

    Rashmi Dhital1, Jia Yin Wan2, Kenneth Kalunian3 and Wendy Cozen4, 1UC San Diego, Brentwood, TN, 2Samueli School of Public Health, University of California Irvine, Irvine, CA, 3University of California San Diego, La Jolla, CA, 4University of California Irvine, Irvine

    Background/Purpose: Systemic lupus erythematosus (SLE) is influenced by both genetic and environmental factors. Twin studies in SLE have shown varying levels of concordance. This study…
  • Abstract Number: 1879 • ACR Convergence 2024

    Prevalence of Relapsing Polychondritis in Colombia: Data from the National Health Registry 2018 – 2023

    Mario Bautista-Vargas1, Adrian Romero-Ocampo2, Juan José Pino Vélez3, juliana Muñoz-Bedoya4 and Diego Rosselli5, 1Mayo Clinic, Rochester, Minnesota, USA., Rochester, MN, 2Universidad de Antioquia, Medellín – Colombia, Medellin, Antioquia, Colombia, 3Universidad de Antioquia, Envigado, Antioquia, Colombia, 4Universidad Corpas, Bogotá, Colombia, 5Pontificia Universidad Javeriana, Bogotá, Colombia

    Background/Purpose: The implementation of the SISPRO system enables it to function as a tool capable of collecting pertinent health system data. This information is publicly…
  • Abstract Number: 1902 • ACR Convergence 2024

    Ixekizumab for the Treatment of Patients with Spondyloarthritis – Real-world Evidence from the Nationwide Danish Registry, DANBIO

    Kasper Yde Jensen1, Merete Hetland2 and Bente Glintborg3, 1Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, 2DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark, Glostrup, Denmark, 3DANBIO, Rigshospitalet Glostrup and University of Copenhagen, Virum, Denmark

    Background/Purpose: Clinical trials have provided robust evidence of the efficacy of ixekizumab, an IL-17 inhibitor, in improving the signs and symptoms of psoriatic arthritis (PsA)…
  • Abstract Number: 2222 • ACR Convergence 2024

    Primary Lung Involvement in Early Rheumatoid Arthritis

    Martí Aguilar Coll1, Javier Narvaez-García2, Alejandro Robles Pérez1, Patricio Luburich1, Vanesa Vicens-Zygmunt3, Gualadalupe Bermudo3, Santiago Bolivar1, Pol Maymó3, Judith Palacios1, Monserrat Roig Kim2, Laia De Daniel2, Maria Molina-Molina3 and Joan Miquel Nolla1, 1Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain, 2Hospital Universitario de Bellvitge, Barcelona, Spain, 3Hospital Universitario de Bellvitge., Barcelona, Spain

    Background/Purpose: Since there is broad variability within the studies investigating this issue, it is not possible nowadays to reliably establish prevalence and incidence of rheumatoid…
  • Abstract Number: 2553 • ACR Convergence 2024

    Predictors of Biologic and Targeted Synthetic DMARD Initiation for Rheumatoid Arthritis Across Underserved Patient Groups: Insights from a National Cohort Study

    Mark Russell1, Mark Gibson2, Benjamin Zuckerman1, Kanta Kumar3, Shirish Dubey4, Maryam Adas2, Edward Alveyn2, Samir Patel1, Zijing Yang1, Katie Bechman2, Elizabeth Price5, Sarah Gallagher6, Andrew Cope2, Sam Norton1 and James Galloway7, 1King's College London, London, England, United Kingdom, 2King's College London, London, United Kingdom, 3University of Birmingham, Birmingham, United Kingdom, 4Oxford University Hospitals NHS FT, Oxford, United Kingdom, 5Great Western Hospital NHS Foundation Trust, Swindon, England, United Kingdom, 6British Society for Rheumatology, London, United Kingdom, 7Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Quantifying healthcare inequality is essential to addressing the imbalance in outcomes attributable to age, gender, ethnicity and multimorbidity. In this study, we analysed differences…
  • Abstract Number: 0142 • ACR Convergence 2024

    The Impact of Hospital Region on Mortality and Other Outcomes in Patients with Gout: A Two-Year Nationwide Analysis

    Nidaa Rasheed1, kHALED ABDULLAH2 and Candice Reyes3, 1UCSF Fresno, Fresno, CA, 2UCSF FRESNO, FRESNO, 3VACCHCS, Fresno, CA

    Background/Purpose: Gout is characterized by chronic inflammatory arthritis caused by the deposition of monosodium urate crystals and leads to increased risk of complications, such as…
  • Abstract Number: 0268 • ACR Convergence 2024

    Weight Loss Induced by Anti-obesity Medications and Gout Among Overweight and Obesity Individuals: A Population-based Cohort Study

    Jie Wei1, Yilun Wang2, Nicola Dalbeth3, Junqing Xie4, Jing Wu5, Chao Zeng6, Guanghua Lei7 and Yuqing Zhang8, 1Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic), 2Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 3University of Auckland, Auckland, New Zealand, 4Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 5Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, China (People's Republic), 6Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic), 7Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 8Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School; The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Weight loss is conditionally recommended for gout management; however, the magnitude of the effect of weight loss on incident gout and recurrent gout flares…
  • Abstract Number: 0490 • ACR Convergence 2024

    Improvements in Peri-fracture Care in Rheumatoid Arthritis (RA) Have Offset Increased Mortality

    Owen Taylor-Williams1, Johannes Nossent2 and Charles Inderjeeth3, 1University of Western Australia, Perth, Western Australia, Australia, 2University of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia, 3SCGH and OPH Group & University of Western Australia, Perth, Western Australia, Australia

    Background/Purpose: Hip or pelvis fractures (HOP) are common osteoporotic fractures (OP) with significant risks of medical complications, placement into care, reduced quality of life and…
  • Abstract Number: 0976 • ACR Convergence 2024

    Assessment of Current Trends in Demographic and Clinical Characteristics of Male Patients with Rheumatoid Arthritis in North India

    BHARAT KUMAR SINGH1 and Seema Singh2, 1CK Birla Hospitals, Jaipur, JAIPUR, Rajasthan, India, 2RAJASTHAN UNIVERSITY OF HEALTH SCIENCES, JAIPUR, Rajasthan, India

    Background/Purpose: Gender differences in rheumatoid arthritis (RA) are well-established, with women more prone to developing RA than men. However, understanding the impact of gender on…
  • Abstract Number: 1003 • ACR Convergence 2024

    Association Between Metabolic Markers and Knee Osteoarthritis: A Cross-sectional Study Using the Korea National Health and Nutrition Examination Survey 2009 to 2013

    Junyong Park, Minkook Son, Sang Yeob Lee, Won Tae Chung and Sung Won Lee, Dong-A University College of Medicine, Busan, Republic of Korea

    Background/Purpose: Low-grade, prolonged inflammation of involved joint is characteristic of osteoarthritis (OA) pathogenesis. Thus susceptibility to inflammation has been considered as a risk factor for…
  • Abstract Number: 1200 • ACR Convergence 2024

    Prevalence and Joint Involvement Patterns of Erosive and Non-erosive Hand Osteoarthritis in the General Population in China

    Jing Ye1, Yuqing Wang1, Tuo Yang2, David Hunter3, Yuqing Zhang4, Weiya Zhang5, Michael Doherty5, Jiatian Li1, wei Li1, Zeqin Wen1, Chao Zeng6, Guanghua Lei7 and Jie Wei8, 1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 2Health Management Center, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 3Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 4Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School; The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Academic Rheumatology, School of Medicine, University of Nottingham; Pain Centre Versus Arthritis, University of Nottingham, Nottingham, United Kingdom, 6Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic), 7Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 8Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic)

    Background/Purpose: Erosive hand osteoarthritis (HOA) poses challenges due to its aggressive nature and limited epidemiological insights. We aimed to describe the prevalence and joint involvement…
  • Abstract Number: 1494 • ACR Convergence 2024

    Trajectories of Disease Evolution upon Treatment Initiation in Systemic Lupus Erythematosus: Pooled Results from Three Randomized Clinical Trials of Belimumab

    Ioannis Parodis1, Julius Lindblom2, Alexandre Tsoi3, Dionysis Nikolopoulos4 and Lorenzo Beretta5, 1Karolinska Institutet, Karolinska University Hospital; Örebro University, Solna, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Karolinska Institute, Stockholm, Sweden, 4Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden, 5Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano, Milan, Milan, Italy

    Background/Purpose: The efficacy of belimumab in treating SLE has been demonstrated in several phase 3 randomized clinical trials (RCTs). These trials showed belimumab efficacy on…
  • Abstract Number: 1880 • ACR Convergence 2024

    Statewide Burden of Osteoarthritis in India and Its Trend from 1990-2021: A Benchmarking Analysis

    Rafael Sanchez-Dopazo,1, malay rathod2, Ashwinikumar Shandilya3, Janmay Vala4, Eva Kalra5, Tapan Giri6, Saif Syed7, Mohit Lakkimsetti8, Juhi Patel9, VISHRANT AMIN10 and Hardik Desai11, 1Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 2Monmouth Medical Center, Rutgers University, Ewing, NJ, 3Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Trident Medical Cente, Charleston, SC, 6BJ Medical College, Pune, Pune, Maharashtra, India, 7Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 8Mamata Medical College,Khammam, Khammam, Telangana, India, 9GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 10GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 11Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) imposes a significant health burden globally, with India experiencing substantial demographic and epidemiological changes over the past three decades. This study addresses…
  • Abstract Number: 1904 • ACR Convergence 2024

    Evaluation of the Economic Burden of Psoriatic Arthritis: Assessment of Direct Costs Using National Administrative Databases at National Level

    Wilson Bautista-Molano1, Ingrid Ramirez-bolivar2, Cristina Pinilla-Forero3 and Luz A Ruiz4, 1University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia, 2Janssen, Bogotá, Colombia, 3Janssen, Bogotá, 4CODENTMED, Bogotá, Colombia

    Background/Purpose: Psoriatic arthritis (PsA) is a high-cost disease due to its significant impact on patients' quality of life and the extensive resources required for its…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology